MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202517130960 A) filed by Gmp Biotechnology Limited, Hong Kong, on Dec. 23, 2025, for 'tgfb2-irf5 therapeutics for cancer.'
Inventor(s) include Trieu, Vuong.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "This invention relates to agents, uses, and methods for treating cancer with an agent for suppressing expression of IRF5. Synergistic therapies include agents, uses, and methods for treating cancer with an agent for suppressing expression of IRF5 in combination with agents for suppressing expression of TGF-2. One or more biomarkers can be use...